Intratumoral blood flow in uterine myoma correlated with a lower tumor size and volume, but not correlated with cell proliferation or angiogenesis

Obstetrics and Gynecology

Volumn 87, Issue 6, 1996, Pages 1019-1024

  Huang, Soon Cen ^a   Yu, Cheng Hsiang ^a   Huang, Ray Tsung ^a   Hsu, Keng Fu ^a   Tsai, Yi Chang ^a   Chou, Cheng Yang ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; CYCLINE; EOSIN; HEMATOXYLIN;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD FLOW VELOCITY; CELL PROLIFERATION; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; PRIORITY JOURNAL; PULSATILE FLOW; TRANSVAGINAL ECHOGRAPHY; TUMOR BLOOD FLOW; TUMOR VOLUME; UTERUS MYOMA; UTERUS SURGERY;

EID: 0030006897     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00073-7     Document Type: Article

References (27)

1. Fleischer AC, Rodgers WH, Kepple DM, Williams LL, Jones HW III. Color Doppler sonography of ovarian masses: A multiparameter analysis. J Ultrasound Med 1993;12:41-8.
2. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasis to neoplasia. Nature 1989;339:58-61.
3. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:65-71.
4. Paweletz N, Knierim M. Tumor-related angiogenesis. Crit Rev Oncol Hematol 1989;9:197-242.
5. Liotta LA, Steeg PS, Stetler-Stevenson WJ. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991;64:327-36.
6. West JB. Dynamics of the peripheral circulation. In: West JB, ed. Physiological basis of medical pratice. 12th ed. Baltimore, Maryland: Williams & Wilkins, 1991:138-58.
7. Huang RT, Chou CY, Chang CH, Yu CH, Huang SC, Yao BL. Differentiation between adenomyoma and leiomyoma with transvaginal ultrasonography. Ultrasound Obstet Gynecol 1995;5:47-50.
8. Matta WHM, Shaw RW, Nye M. Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin. Br J Obstet Gynaecol 1989;96:200-6.
9. Chou CY, Chang CH, Yao BL, Kuo HC. Color Doppler ultrasonography and serum CA 125 in the differentiation of benign and malignant ovarian tumors. JCU 1994;22:491-6.
10. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
11. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
12. Bosari S, Lee AKC, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-61.
13. Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-94.
14. Visakorpi T. Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. J Pathol 1992;168:7-13.
15. Bravo R, MacDonald-Bravo H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Associated with DNA replication sites. J Cell Biol 1987;105:1549-54.
16. Suzuka I, Daidoji H, Matsuoka M, Kadowaki K, Takasaki Y, Nakane PK, et al. Gene for proliferating-cell nuclear antigen (DNA polymerase auxiliary protein) is present in both mammalian and higher plant genomes. Proc Natl Acad Sci U S A 1989;86:3189-93.
17. Baserga R. Growth regulation of the PCNA gene. J Cell Sci 1991;98:433-6.
18. McCormick D, Hall PA. The complexities of proliferating cell nuclear antigen. Histopathology 1992;21:591-4.
19. Hsieh CY, Wu CC, Chen TM, Chen CA, Chen CL, Wang JF, et al. Clinical significance of intratumoral blood flow in cervical carcinoma assessed by color Doppler ultrasound. Cancer 1995;75:2518-22.
20. Ribatti D, Vacca A, Roncali L, Dammacco F. Angiogenesis under normal and pathological conditions. Haematologica 1991;76:311-20.
21. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML, Merino MJ. Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 1995;147:33-41.
22. Gammill SL, Shipkey FH, Himmelfrab EH, Parvey LS, Rabinowitz JG. Roentgenology-pathology correlative study of neovascularity. AJR 1976;126:376-85.
23. Taylor KJW, Ramos I, Carter D, Morse SS, Snower D, Fortune K. Correlation of Doppler US tumor signals with neovascular morphologic features. Radiology 1988;166:57-62.
24. Hata T, Hata K, Senoh D, Makihara K, Aoki S, Takamiya O, et al. Doppler ultrasound assessment of tumor vascularity in gynecologic disorders. J Ultrasound Med 1989;8:309-14.
25. Hata K, Makihara T, Hata T, et al. Transvaginal color Doppler imaging for hemodynamic assessment of reproductive tract tumors. Int J Gynecol Obstet 1991;36:301-8.
26. Kurjak A. Uterine masses. In: Kurjak A, Zalud I, eds. Transvaginal color Doppler. Park Ridge: Parthenon, 1991:123-34.
27. Carter JR, Lau M, Saltzman AK, Hartenbach EM, Chen MD, Johnson PR, et al. Gray scale and color flow Doppler characterization of uterine tumors. J Ultrasound Med 1994;13:835-40.